Cell Cycle Inhibitors and Outcome after Radiotherapy in Bladder Cancer Patients
Ranveig Røtterud(Norwegian Cancer Society), Sophie D. Fosså(Oslo University Hospital), Ruth Holm(University of Aleppo), Aasmund Berner(Oslo University Hospital), Erik O. Pettersen(University of Oslo), Dag Rune Olsen(Oslo University Hospital)
Cited by 3
Related Papers
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
|The Lancet|2008|873
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
|Journal of Clinical Oncology|2001|628